Bcl-2 expression by CD4 T lymphocytes in Vogt-Koyanagi-Harada disease

Ocular Immunology and Inflammation

Volumn 10, Issue 2, 2002, Pages 93-103

  Ohta, Kouichi ^a   Yoshimura, Nagahisa ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bcl 2; Cerebrospinal fluid; sFasL; Vogt Koyanagi Harada disease

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; FAS ANTIBODY; FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CELL LEVEL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VOGT KOYANAGI SYNDROME;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; AQUEOUS HUMOR; CD4-POSITIVE T-LYMPHOCYTES; CEREBROSPINAL FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 0038670322     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.1076/ocii.10.2.93.13984     Document Type: Article

References (26)

1. Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 1978;22:9-35.
2. Norose K, Yano A, Aosai F, Segawa K. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 1990;31:1210-1216.
3. Sugita M, Nakamura S, Tanaka S, Isoda F, Okuda K, Ohno S. Flow cytometric analysis of surface markers of cerebrospinal fluid cells and peripheral blood lymphocytes from VKH disease. In: Nussenblatt RB, Whitcup SM, Capsi RR, Gery I, eds. Advances in ocular immunology. Amsterdam: Elsevier Science B.V., 1994;385-388.
4. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, Mckean JP, Korsmeyer SJ. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989;57:79-88.
5. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 1991;67:889-899.
6. Ohta K, Norose K, Wang X-C, Ito S, Yano A, Segawa K. Apoptosis-related fas antigen on memory T cells in aqueous humor of uveitis patients. Curr Eye Res. 1996;15:299-306.
7. Ohta K, Yoshimura N. Expression of Fas antigen on helper T lymphocytes in Vogt-Koyanagi-Harada disease. Graefe's Arch Clin Exp Ophthalmol. 1998;236:434-439.
8. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S. Fas ligand in human serum. Nat Med. 1996;5:7-16.
9. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima S, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233-243.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;8:1765-1773.
11. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of tumor necrosis factor family. Cell. 1993;75:1169-1178.
12. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. Eur Mol Biol Organ (EMBO) J. 1995;14:1129-1135.
13. Kayagaki N, Kawasaki A, Ebara T, Ohmoto H, Ikeda S, Yoshino K, Okumura K, Yagita H. Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 1995;182;1777-1783.
14. Sotozono C, Sano Y, Suzuki T, Tada R, Ikeda T, Nagata S, Kinoshita S. Soluble Fas ligand expression in the ocular fluids of uveitis patients. Curr Eye Res. 2000;20:54-57.
15. Sugita S, Taguchi C, Takase H, Sagawa K, Sueda J, Fukushi K, Hikita N, Watanabe T, Itoh K, Mochizuki M. Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis. Br J Ophthalmol. 2000;84:1130-1134.
16. Saito M, Nakamura N, Nagai M, Shirakawa K, Sato H, Kawahigashi N, Furukawa Y, Usuku K, Nakagawa M, Izumo S, Osame M. Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients. J Neuroimmunol. 1999;98:221-226.
17. Hockebery D, Nunez G, Miliman C, Schreiber RD, Korsmeyer SJ. bcl-2 is an inner mitochondria membrane protein that blocks programmed cell death. Nature. 1990;348:334-346.
18. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol. 1993;151:621-627.
19. Tamura A, Katsumata M, Greene MI, Yui K. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice. Cell Immunol. 1996;168:220-228.
20. Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S. Bcl-2 and fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. Eur Mol Biol Organ (EMBO) J. 1995;14:6136-6147.
21. Rose LM, Latchman DS, Isenberg DA. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Br J Rheumatol. 1995;34:316-320.
22. Ohsako S, Hara M, Harigai M, Fukusawa C, Kashiwasaki S. Expression and function of Fas antigen and Bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol. 1994;73:109-114.
23. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5:7-16.
24. Chan CC, Matteson DM, Li Q, Whitcup SM, Nussenblatt RB. Apoptosis in patients with posterior uveitis. Arch Ophthalmol. 1997;115:1559-1567.
25. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol. 1992;149:3753-3758.
26. Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH, Weller M. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J Immunol. 1997;159:2108-2115.